Literature DB >> 3436852

Analysis of structural changes in the stria vascularis following chronic gentamicin treatment.

A Forge1, A Wright, S J Davies.   

Abstract

Changes in the stria vascularis following chronic gentamicin treatment have been examined using quantitative methods. Albino guinea pigs were given gentamicin at 100 mg.kg-1.day-1 subcutaneously for 10 days. Comparisons were made of strial tissue from the treated animals sacrificed either 1 h or 4 weeks following the last injection with that from saline-injected controls. Strial width (spiral prominence to Reissner's membrane) and marginal cell (MC) number across the stria were determined from scanning electron micrographs. Strial thickness (endolymphatic surface to spiral ligament) and the volume fractions of the strial components (MCs, intermediate cells (ICs), basal cells (BCs) and capillaries) were derived from thin sections. Qualitative changes to both MCs and ICs were apparent 1 h after the last injection. At four weeks post-treatment, there was a small, but statistically significant, decrease in the number of marginal cells and a highly significant decrease in strial thickness. This was almost entirely due to a highly significant decrease in the volume fraction of MCs (i.e. shrinkage). The volume fraction of ICs was increased but this could be accounted for by MC shrinkage; after allowing for the reduction in strial thickness, the volume occupied by ICs was unchanged. Thus, following chronic gentamicin treatment, the stria is affected but significant progressive and permanent structural effects are confined to the marginal cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436852     DOI: 10.1016/0378-5955(87)90195-x

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  13 in total

Review 1.  [Endolymph homeostasis and Menière's disease: fundamentals, pathological changes, aminoglycosides].

Authors:  O Gleich; J Strutz; K Schmid
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

2.  Fine structure of the intracochlear potential field. I. The silent current.

Authors:  M Zidanic; W E Brownell
Journal:  Biophys J       Date:  1990-06       Impact factor: 4.033

3.  Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.

Authors:  Keiko Hirose; Eisuke Sato
Journal:  Hear Res       Date:  2010-10-31       Impact factor: 3.208

4.  A new immunohistochemical method for the detection of gentamicin in inner ear fluid compartments.

Authors:  M Mihelic-Rapp; W Giebel
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

5.  Localization of gentamicin uptake in the acutely isolated inner ear of the rat.

Authors:  Katharina Schmid; Jürgen Strutz; Otto Gleich; Pingling Kwok
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-03-28

6.  Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo.

Authors:  C F Dai; D Mangiardi; D A Cotanche; P S Steyger
Journal:  Hear Res       Date:  2006-02-08       Impact factor: 3.208

7.  Trafficking of systemic fluorescent gentamicin into the cochlea and hair cells.

Authors:  Qi Wang; Peter S Steyger
Journal:  J Assoc Res Otolaryngol       Date:  2009-03-03

8.  Rapid hair cell loss: a mouse model for cochlear lesions.

Authors:  Ruth Rebecca Taylor; Graham Nevill; Andrew Forge
Journal:  J Assoc Res Otolaryngol       Date:  2007-12-04

9.  Different uptake of gentamicin through TRPV1 and TRPV4 channels determines cochlear hair cell vulnerability.

Authors:  Jeong-Han Lee; Channy Park; Se-Jin Kim; Hyung-Jin Kim; Gi-Su Oh; AiHua Shen; Hong-Seob So; Raekil Park
Journal:  Exp Mol Med       Date:  2013-03-08       Impact factor: 8.718

Review 10.  Age-related hearing impairment and the triad of acquired hearing loss.

Authors:  Chao-Hui Yang; Thomas Schrepfer; Jochen Schacht
Journal:  Front Cell Neurosci       Date:  2015-07-27       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.